Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 3/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.35 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.35 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bucillamine SCHEMBL5060887 | 1.00 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Bucillamine SCHEMBL522713 | 1.00 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Bucillamine SCHEMBL930021 | 1.00 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Bucillamine SCHEMBL4632094 | 0.91 | MAPT (0.50) | MAPTKDM4ETHRBALOX15NFKB1 | |
| Bucillamine SCHEMBL28086441 | 0.88 | PTGS1 (0.56) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL6661780 | 0.86 | KDM4E (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL6661779 | 0.86 | KDM4E (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL9324856 | 0.86 | KDM4E (0.61) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL929192 | 0.85 | ACE (0.51) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL929188 | 0.85 | ACE (0.51) | MAPTKDM4ETHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743450-A1 | L-LYSINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF | ENYO Pharma (FR) | 2026-05-20 | — | — | EP | claimed |
| EP-4743451-A1 | TROMETHAMINE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF | ENYO Pharma (FR) | 2026-05-20 | — | — | EP | claimed |
| EP-4743449-A1 | L-ARGININE SALT OF 4-CHLORO-5-[4-(2,6-DICHLOROPHENYL)SULFONYLPIPERAZIN-1-YL]-1-BENZOFURAN-2-CARBOXYLIC ACID AND VARIOUS FORMS THEREOF | ENYO Pharma (FR) | 2026-05-20 | — | — | EP | claimed |
| EP-4739291-A2 | ADMINISTRATION OF KERATOLYTICS TO OCULAR AND PERIOCULAR SURFACES | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4739293-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | AZURA OPHTHALMICS LTD (IL) | 2026-05-13 | — | — | EP | claimed |
| EP-4731204-A2 | SELECTIVE RBP4 ANTAGONIST AND C20-D3-RETINOL FOR TREATING MACULAR DEGENERATION, NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), AND GOUTY ARTHRITIS (GOUT) | The Trustees Of Columbia University In The City Of New York (US) | 2026-04-29 | — | — | EP | claimed |
| US-20260109732-A1 | LIPID AMINES | MODERNATX INC (US) | 2026-04-23 | — | — | US | claimed |
| US-20260109705-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS | Azura Ophthalmics Ltd. (IL) | 2026-04-23 | — | — | US | claimed |
| US-20260083127-A1 | Thiolactone-Derived Compounds for Generating Nitric Oxide and Methods of Forming the Same | STERILE STATE, LLC (US) | 2026-03-26 | — | — | US | claimed |
| WO-2026041906-A1 | SEMI-SOLID PHARMACEUTICAL COMPOSITION MICRO-DISPENSER | Azura Ophthalmics Ltd. (IL) | 2026-02-26 | — | — | WO | claimed |
| US-5266595-A | Bucillamine | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1993-11-30 | — | — | US | claimed |
| EP-0551180-A1 | Use of bucillamine for the manufacture of a medicament for the treatment of cystinuria | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1993-07-14 | — | — | EP | claimed |
| WO-1993003697-A1 | TRANSDERMAL FORMULATIONS FOR ADMINISTERING PRAZOSIN | CYGNUS THERAPEUTIC SYSTEMS (US) | 1993-03-04 | — | — | WO | claimed |
| US-5149614-A | DEVELOPER COMPOSITIONS FOR PS PLATES AND METHOD FOR DEVELOPING THE SAME WHEREIN THE DEVELOPER COMPOSITION CONTAINS A SURFACTANT HAVING AN ARYL GROUP, AN OXYALKYLENE GROUP AND A SULFATE ESTER OR SULFONIC ACID GROUP | FUJI PHOTO FILM CO., LTD. (JP) | 1992-09-22 | — | — | US | claimed |
| US-5126229-A | No background contamination | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-30 | — | — | US | claimed |
| EP-0072868-B1 | CYCLODEXTRIN CLATHRATE COMPOUNDS OF SULFUR-CONTAINING COMPOUNDS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1985-07-24 | — | — | EP | claimed |
| US-4482709-A | Inclusion compounds of cyclodextrin with sulfur-containing compounds | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1984-11-13 | — | — | US | claimed |
| EP-0072868-A1 | CYCLODEXTRIN CLATHRATE COMPOUNDS OF SULFUR-CONTAINING COMPOUNDS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1983-03-02 | — | — | EP | claimed |
| US-4305958-A | Cysteine derivatives | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1981-12-15 | — | — | US | claimed |
| US-4241086-A | Method for treating rheumatism | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 1980-12-23 | — | — | US | claimed |